Sernova Biotherapeutics (OTCMKTS:SEOVF) Issues Quarterly Earnings Results

Sernova Biotherapeutics (OTCMKTS:SEOVF) posted its quarterly earnings results on Thursday. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01), Zacks reports.

Sernova Biotherapeutics Price Performance

Sernova Biotherapeutics stock opened at $0.11 on Friday. The company has a market capitalization of $41.54 million, a PE ratio of -2.75 and a beta of 0.82. The firm has a fifty day simple moving average of $0.12 and a two-hundred day simple moving average of $0.11. Sernova Biotherapeutics has a twelve month low of $0.09 and a twelve month high of $0.16.

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.